Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 139

Similar articles for PubMed (Select 19933914)

1.

Early-stage, lymphocyte-predominant Hodgkin's lymphoma: patient outcomes from a large, single-institution series with long follow-up.

Chen RC, Chin MS, Ng AK, Feng Y, Neuberg D, Silver B, Pinkus GS, Stevenson MA, Mauch PM.

J Clin Oncol. 2010 Jan 1;28(1):136-41. doi: 10.1200/JCO.2009.24.0945. Epub 2009 Nov 23.

2.

Mantle irradiation alone for pathologic stage I and II Hodgkin's disease: long-term follow-up and patterns of failure.

Liao Z, Ha CS, Vlachaki MT, Hagemeister F, Cabanillas F, Hess M, Tucker S, Cox JD.

Int J Radiat Oncol Biol Phys. 2001 Jul 15;50(4):971-7.

PMID:
11429225
3.

Long-term outcome after radiotherapy alone for lymphocyte-predominant Hodgkin lymphoma: a retrospective multicenter study of the Australasian Radiation Oncology Lymphoma Group.

Wirth A, Yuen K, Barton M, Roos D, Gogna K, Pratt G, Macleod C, Bydder S, Morgan G, Christie D.

Cancer. 2005 Sep 15;104(6):1221-9.

4.

Clinical presentation and outcome in lymphocyte-predominant Hodgkin's disease.

Bodis S, Kraus MD, Pinkus G, Silver B, Kadin ME, Canellos GP, Shulman LN, Tarbell NJ, Mauch PM.

J Clin Oncol. 1997 Sep;15(9):3060-6.

PMID:
9294468
5.

Localized extranodal lymphoma of the head and neck: retrospective analysis of a series of 107 patients from a single institution.

Frata P, Buglione M, Grisanti S, Bonetti B, Vitali E, De Stefani A, Magri E, Peveri A, Marini G, Rossi G, Magrini SM.

Tumori. 2005 Nov-Dec;91(6):456-62.

PMID:
16457141
6.

Long-term outcome of treatment for Ann Arbor Stage I Hodgkin's disease: prognostic factors for survival and freedom from progression.

Vlachaki MT, Hagemeister FB, Fuller LM, Besa PC, Hess MA, Brown B, Cabanillas F, Cox JD.

Int J Radiat Oncol Biol Phys. 1997 Jun 1;38(3):593-9.

PMID:
9231684
7.

Stage IA-IIB Hodgkin's disease: management and outcome of extensive thoracic involvement.

Hughes-Davies L, Tarbell NJ, Coleman CN, Silver B, Shulman LN, Linggood R, Canellos GP, Mauch PM.

Int J Radiat Oncol Biol Phys. 1997 Sep 1;39(2):361-9.

PMID:
9308940
8.

Long-term outcome of treatment for Ann Arbor stage 1 Hodgkin's disease: patterns of failure, late toxicity and second malignancies.

Vlachaki MT, Ha CS, Hagemeister FB, Fuller LM, Rodriguez MA, Besa PC, Hess MA, Brown B, Cabanillas F, Cox JD.

Int J Radiat Oncol Biol Phys. 1997 Oct 1;39(3):609-16.

PMID:
9336140
9.

Non-Hodgkin's lymphoma of the stomach: treatment outcomes for 57 patients over a 20-year period.

Ho CL, Hsieh AT, Dai MS, Chen YC, Kao WY, Chao TY.

J Chin Med Assoc. 2005 Jan;68(1):11-5.

PMID:
15742857
10.

Improved survival in patients with limited stage IIIA Hodgkin's disease treated with combined radiation therapy and chemotherapy.

Marcus KC, Kalish LA, Coleman CN, Shulman LN, Rosenthal DS, Canellos GP, Mauch PM.

J Clin Oncol. 1994 Dec;12(12):2567-72.

PMID:
7989930
11.

Long-term follow-up of patients treated with primary radiotherapy for supradiaphragmatic Hodgkin's disease at St. Jude Children's Research Hospital.

Shah AB, Hudson MM, Poquette CA, Luo X, Wilimas JA, Kun LE.

Int J Radiat Oncol Biol Phys. 1999 Jul 1;44(4):867-77.

PMID:
10386644
12.

Involved-nodal radiation therapy as a component of combination therapy for limited-stage Hodgkin's lymphoma: a question of field size.

Campbell BA, Voss N, Pickles T, Morris J, Gascoyne RD, Savage KJ, Connors JM.

J Clin Oncol. 2008 Nov 10;26(32):5170-4. doi: 10.1200/JCO.2007.15.1001. Epub 2008 Oct 6.

13.

Analysis of in-field control and late toxicity for adults with early-stage Hodgkin's disease treated with chemotherapy followed by radiotherapy.

Chronowski GM, Wilder RB, Tucker SL, Ha CS, Younes A, Fayad L, Rodriguez MA, Hagemeister FB, Barista I, Cabanillas F, Cox JD.

Int J Radiat Oncol Biol Phys. 2003 Jan 1;55(1):36-43.

PMID:
12504034
14.

Radiation therapy in clinical stage I and II Hodgkin's disease. The Princess Margaret Hospital Lymphoma Group.

Gospodarowicz MK, Sutcliffe SB, Bergsagel DE, Chua T.

Eur J Cancer. 1992;28A(11):1841-6.

PMID:
1389522
15.

Subdiaphragmatic stage I & II Hodgkin's disease: long-term follow-up and prognostic factors.

Liao Z, Ha CS, Fuller LM, Hagemeister FB, Cabanillas F, Tucker SL, Hess MA, Cox JD.

Int J Radiat Oncol Biol Phys. 1998 Jul 15;41(5):1047-56.

PMID:
9719114
16.

Limited field radiotherapy for early stage, infra-diaphragmatic Hodgkin's lymphoma.

Harris MA, Radford JA, Deakin DP, James RD, Swindell R, Cowan RA.

Clin Oncol (R Coll Radiol). 2004 Feb;16(1):53-7.

PMID:
14768756
17.

Mantle irradiation alone for clinical stage I-II Hodgkin's disease: long-term follow-up and analysis of prognostic factors in 261 patients.

Wirth A, Chao M, Corry J, Laidlaw C, Yuen K, Ryan G, Byram D, Davis S, Kiffer J, Quong G, Liew K.

J Clin Oncol. 1999 Jan;17(1):230-40.

PMID:
10458238
18.

Resection alone in 58 children with limited stage, lymphocyte-predominant Hodgkin lymphoma-experience from the European network group on pediatric Hodgkin lymphoma.

Mauz-Körholz C, Gorde-Grosjean S, Hasenclever D, Shankar A, Dörffel W, Wallace WH, Schellong G, Robert A, Körholz D, Oberlin O, Hall GW, Landman-Parker J.

Cancer. 2007 Jul 1;110(1):179-85.

19.

Radiotherapy alone for lymphocyte-predominant Hodgkin's disease.

Schlembach PJ, Wilder RB, Jones D, Ha CS, Fayad LE, Younes A, Hagemeister F, Hess M, Cabanillas F, Cox JD.

Cancer J. 2002 Sep-Oct;8(5):377-83.

PMID:
12416895
20.

The optimal dose of radiation in Hodgkin's disease: an analysis of clinical and treatment factors affecting in-field disease control.

Mendenhall NP, Rodrigue LL, Moore-Higgs GJ, Marcus RB Jr, Million RR.

Int J Radiat Oncol Biol Phys. 1999 Jun 1;44(3):551-61.

PMID:
10348284
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk